反応式
C([Li])CCC.[Br-].[CH3:7][N:8]([CH3:30])[CH2:9][CH2:10][P+](C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1.[O:31]([CH2:38][CH2:39][CH2:40][N:41]1[CH2:46][CH2:45][C:44](=O)[CH2:43][CH2:42]1)[C:32]1[CH:37]=[CH:36][CH:35]=[CH:34][CH:33]=1.[ClH:48]>C1COCC1.CCOCC.[Pd]>[ClH:48].[ClH:48].[CH3:7][N:8]([CH3:30])[CH2:9][CH2:10][CH:44]1[CH2:45][CH2:46][N:41]([CH2:40][CH2:39][CH2:38][O:31][C:32]2[CH:37]=[CH:36][CH:35]=[CH:34][CH:33]=2)[CH2:42][CH2:43]1参加物
反応物 4
生成物 1
試薬・触媒・溶媒 3
実験手順
In a similar manner to Example 28, n-butyllithium (25.2 ml, 2.5M solution in hexanes) was added to a suspension of (2-dimethylaminoethyl)triphenylphosphonium bromide (28.7 g) in dry THF (200 ml). This mixture was then treated with a solution of 1-(3-phenoxypropyl)-4-piperidone (14.7 g) in THF (20 ml). The oil obtained after work up (6.24 g) was hydrogenated in IMS at 1 atmosphere over 10% palladium charcoal over 16 hours. The catalyst was removed by filtration. The filtrate was evaporated and the residue was dissolved in petroleum ether, b.p. 60°-80° C. The solution was dried and evaporated to give an oil which was dissolved in ether and acidified with ethereal hydrogen chloride to yield a precipitate. The precipitate was collected by filtration and recrystallised from IMS to give 4-(2-dimethylaminoethyl)-1-(3-phenoxypropyl)piperidine dihydrochloride, m.p. 294°-295° C.
後処理
- customThe oil obtained after work up (6.24 g)
- customThe catalyst was removed by filtration
- customThe filtrate was evaporated
- dissolutionthe residue was dissolved in petroleum ether
- customThe solution was dried
- customevaporated
- customto give an oil which
- customto yield a precipitate
- filtrationThe precipitate was collected by filtration
- customrecrystallised from IMS
出典と根拠
- ORDレコード
- ord-4b8dc02404704dde86b51b67f074d2ad
- 出典データセット
- uspto-grants-1998_06
- 特許番号
- US05760035
関連ノート
読み込み中…